BIM45205 - Specific deductions: gifts: medical supplies: World Health Organisation guidelines: for drug donations

All drug donations should be based on an expressed need and be relevant to the disease pattern in the recipient country. Drugs should not be sent without prior consent by the recipient.
All donated drugs or their generic equivalents should be approved for use in the recipient country and appear on the national list of essential drugs, or, if a national list is not available, on the World Health Organisation model list of essential drugs, unless specifically requested otherwise by the recipient.
The presentation, strength and formulation of donated drugs should, as much as possible, be similar to those of drugs commonly used in the recipient country.
All donated drugs should be obtained from a reliable source and comply with quality standards in both donor and recipient country.
No drugs should be donated that have been issued to patients and then returned to a pharmacy or elsewhere, or were given to health professionals as free samples.
After arrival in the recipient country all donated drugs should have a remaining shelf life of at least one-year. (There are certain exceptions provided for this rule).

All drugs should be labelled in a language that is easily understood by health professionals in the recipient country; the label on each individual container should at least contain the International Non-proprietary Name (INN) or generic name, batch number, dosage form, strength, name of manufacturer, quantity in the container, storage conditions and expiry date.
As much as possible, donated drugs should be presented in larger quantity units and hospital packs.
All drug donations should be packed in accordance with international shipping regulations, and be accompanied by a detailed packing list which specified the contents of each numbered carton by INN, dosage form, quantity, batch number, expiry date, volume, weight and any special storage conditions. The weight per carton should not exceed 50 kilograms. Drugs should not be mixed with other supplies in the same carton.

Recipients should be informed of all drug donations that are being considered, prepared or actually under way.
In the recipient country the declared value of a drug donation should be based upon the wholesale price of its generic equivalent in the recipient country, or, if such information is not available, on the wholesale world-market price for its generic equivalent.
Costs of international and local transport, warehousing, port clearance and appropriate storage and handling should be paid by the donor agency, unless specifically agreed otherwise with the recipient in advance.